Talking Points: 21 November 2022
A quick roundup of the issues driving the healthcare reform conversation.
A quick roundup of the issues driving the healthcare reform conversation.
A quick roundup of the issues driving the healthcare reform conversation.
A quick roundup of the issues driving the healthcare reform conversation.
Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.
A quick roundup of the issues driving the healthcare reform conversation.
Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.
Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.
Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.
Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.
A new study links private equity investments to higher costs; drugmakers profit from donations to patient charities; Medicare Advantage continues to grow; and, a reminder of the critical role that the Medicaid program has played during the ongoing coronavirus public health crisis.